Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and marketing of pharmaceuticals, biotechnology products, and medical devices. Its primary function revolves around creating innovative solutions for unmet medical needs, with a specific focus on therapeutic areas such as oncology, nephrology, immunology, and the central nervous system. Kyowa Kirin's commitment to research and development is underscored by significant investments in cutting-edge biotechnology and partnerships that foster scientific advancements. The company's contribution extends to providing effective healthcare solutions globally, impacting various industries including healthcare, pharmaceuticals, and biotechnology. As a leading player in the pharmaceutical sector, Kyowa Kirin plays a crucial role in advancing medical science and improving patient outcomes through its diverse product offerings and ongoing clinical trials. This makes it an influential entity within Japan's pharmaceutical industry and the global market at large, continuing to drive innovation and therapeutic discoveries.

CEO

Mr. Masashi Miyamoto Ph.D.

Employees

5,669

Website

kyowakirin.com